Gangguan suasana hati terkait menstruasi Gambaran problem psikologis dan intervensinya

Authors

  • Annastasia Ediati Faculty of Psychology, Universitas Diponegoro

DOI:

https://doi.org/10.58959/cjss.v2i1.20

Keywords:

Premenstrual Dysphoric Disorder (PMDD), premenstrual syndrome (PMS), psychosocial impact, review

Abstract

Premenstrual Dysphoric Disorder (PMDD) is a severe mood disorder characterized by emotional and physical symptoms that significantly impair a women's quality of life during the luteal phase of the menstrual cycle. This paper aims to provide a comprehensive overview of the existing literature on PMDD, drawn from leading databases including PubMed, Medline, Scopus, and ScienceDirect. This paper describes what PMDD is, diagnostic criteria for PMDD according to DSM-5 and ICD-11, PMDD assessment instruments, the psychological impact of PMDD and its treatment. Pharmacological interventions, particularly selective serotonin reuptake inhibitors (SSRIs), are emerging as the main treatment options, but non-pharmacological approaches such as cognitive-behavioral therapy are also promising. From previous studies it can be concluded that PMDD has a multidimensional impact on women who experience PMDD. Further research is needed, especially regarding psychosocial impacts, development of PMDD assessment instruments, and psychosocial interventions to alleviate PMDD.

---

Premenstrual Dysphoric Disorder (PMDD) adalah gangguan suasana hati yang parah yang ditandai dengan gejala emosional dan fisik yang secara signifikan mengganggu kualitas hidup wanita selama fase luteal dari siklus menstruasi. Tulisan ini bertujuan untuk memberikan gambaran menyeluruh dari literatur dari database PubMed, Medline, Scopus, dan ScienceDirect. Penelitian ini mendeskripsikan mengenai apa itu PMDD, kriteria diagnostik menurut DSM-5 dan ICD-11, instrumen asesmen PMDD, dampak psikologis PMDD dan penanganannya. Intervensi farmakologis, khususnya inhibitor reuptake serotonin selektif (SSRI), muncul sebagai pilihan pengobatan utama, tetapi pendekatan non-farmakologis seperti terapi perilaku-kognitif juga efektif. Dari hasil analisis terhadap penelitian sebelumnya dapat disimpulkan bahwa PMDD berdampak multidimensi pada perempuan yang mengalami PMDD. Diperlukan penelitian lebih lanjut, khususnya mengenai dampak psikososial, pengembangan instrumen asesmen PMDD, dan intervensi psikososial untuk meringankan PMDD.

References

Cao, S., Jones, M., Tooth, L., & Mishra, G. (2021). Does premenstrual syndrome before pregnancy increase the risk of postpartum depression? Findings from the Australian Longitudinal Study on Women’s Health. Journal of Affective Disorders, 279, 143–148. https://doi.org/10.1016/j.jad.2020.09.130

Carlini, S. V., Weiss, S. J., Mordukhaev, L., Jacob, S., Flynn, H. A., & Deligiannidis, K. M. (2022). Clinical correlates of women endorsing premenstrual suicidal ideation: A cross-sectional study. BioPsychoSocial Medicine, 16(1), 23. https://doi.org/10.1186/s13030-022-00252-3

de Carvalho, A. B., Cardoso, T. A., Mondin, T. C., da Silva, R. A., Souza, L. D. M., Magalhães, P. V. S., & Jansen, K. (2018). Prevalence and factors associated with premenstrual dysphoric disorder a community sample of young adult women. Psychiatry Research, 268(October), 42–45. https://doi.org/10.1016/j.psychres.2018.06.005

Dutta, A., & Sharma, A. (2021). Prevalence of premenstrual syndrome and premenstrual dysphoric disorder in India: A systematic review and meta-analysis. Health Promotion Perspectives, 11(2), 161–170. https://doi.org/10.34172/hpp.2021.20

Eisenlohr-Moul, T. (2019). Premenstrual Disorders: A Primer and Research Agenda for Psychologists. PsyArXiv. https://doi.org/10.31234/osf.io/tw4bd

Hantsoo, L., Rangaswamy, S., Voegtline, K., Salimgaraev, R., Zhaunova, L., & Payne, J. L. (2022). Premenstrual symptoms across the lifespan in an international sample: Data from a mobile application. Archives of Women’s Mental Health, 25(5), 903–910. https://doi.org/10.1007/s00737-022-01261-5

Henshaw, C. A. (2007). PMS: Diagnosis, aetiology, assessment and management: Revisiting… Premenstrual syndrome. Advances in Psychiatric Treatment, 13(2), 139–146. https://doi.org/10.1192/apt.bp.106.003392

Hong, J. P., Park, S., Wang, H.-R., Chang, S. M., Sohn, J. H., Jeon, H. J., Lee, H. W., Cho, S.-J., Kim, B.-S., Bae, J. N., & Cho, M. J. (2012). Prevalence, correlates, comorbidities, and suicidal tendencies of premenstrual dysphoric disorder in a nationwide sample of Korean women. Social Psychiatry and Psychiatric Epidemiology, 47(12), 1937–1945. https://doi.org/10.1007/s00127-012-0509-6

Kuehner, C., & Nayman, S. (2021). Premenstrual Exacerbations of Mood Disorders: Findings and Knowledge Gaps. Current Psychiatry Reports, 23(11), 78. https://doi.org/10.1007/s11920-021-01286-0

O’Brien, P. M. S., Bäckström, T., Brown, C., Dennerstein, L., Endicott, J., Epperson, C. N., Eriksson, E., Freeman, E., Halbreich, U., Ismail, K. M. K., Panay, N., Pearlstein, T., Rapkin, A., Reid, R., Schmidt, P., Steiner, M., Studd, J., & Yonkers, K. (2011). Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: The ISPMD Montreal consensus. Archives of Women’s Mental Health, 14(1), 13–21. https://doi.org/10.1007/s00737-010-0201-3

Ogebe, O., Abdulmalik, J., Bello-Mojeed, M., Holder, N., Jones, H. A., Ogun, O. O., & Omigbodun. (2011). A Comparison of the Prevalence of Premenstrual Dysphoric Disorder and Comorbidities among Adolescents in the United States of America and Nigeria. Journal of Pediatric and Adolescent Gynecology, 24(6), 397–403. https://doi.org/10.1016/j.jpag.2011.07.009

Osborn, E., Brooks, J., O’Brien, P. M. S., & Wittkowski, A. (2021). Suicidality in women with Premenstrual Dysphoric Disorder: A systematic literature review. Archives of Women’s Mental Health, 24(2), 173–184. https://doi.org/10.1007/s00737-020-01054-8

Osborn, E., Wittkowski, A., Brooks, J., Briggs, P. E., & O’Brien, P. M. S. (2020). Women’s experiences of receiving a diagnosis of premenstrual dysphoric disorder: A qualitative investigation. BMC Women’s Health, 20(1), 242. https://doi.org/10.1186/s12905-020-01100-8

Paul, S., & Pal, A. (2022). Premenstrual Syndrome and Premenstrual Dysphoric Disorder: A Review of their History with an Eye on Future. Annals of Indian Psychiatry, 6(4), 393. https://doi.org/10.4103/aip.aip_16_22

Qiao, M., Zhang, H., Liu, H., Luo, S., Wang, T., Zhang, J., & Ji, L. (2012). Prevalence of premenstrual syndrome and premenstrual dysphoric disorder in a population-based sample in China. European Journal of Obstetrics Gynecology and Reproductive Biology, 162(1), 83–86. https://doi.org/10.1016/j.ejogrb.2012.01.017

Sundström-Poromaa, I., Comasco, E., Sumner, R., & Luders, E. (2020). Progesterone – Friend or foe? Frontiers in Neuroendocrinology, 59, 100856. https://doi.org/10.1016/j.yfrne.2020.100856

Tschudin, S., Bertea, P. C., & Zemp, E. (2010). Prevalence and predictors of premenstrual syndrome and premenstrual dysphoric disorder in a population based sample. Archives of Women’s Mental Health, 13, 485–494. https://doi.org/10.1007/s00737-010-0165-3

Wittchen, H.-U., Becker, E., Lieb, R., & Krause, P. (2002). Prevalence, incidence and stability of premenstrual dysphoric disorder in the communityPsych. Psychological Medicine, 32(1), 119–132. https://doi.org/10.1017/S00332917010049

World Health Organization. (2019). GA34.41 Premenstrual dysphoric disorder. In International statistical classification of diseases and related health problems (11th ed.). http://id.who.int/icd/entity/1526774088

Downloads

Published

2023-06-20

Issue

Section

Psychological Assessment and Intervention